• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胺碘酮治疗:最新实用见解

Amiodarone Therapy: Updated Practical Insights.

作者信息

Șorodoc Victorița, Indrei Lucia, Dobroghii Catinca, Asaftei Andreea, Ceasovschih Alexandr, Constantin Mihai, Lionte Cătălina, Morărașu Bianca Codrina, Diaconu Alexandra-Diana, Șorodoc Laurențiu

机构信息

Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.

Second Internal Medicine Department, Sf. Spiridon Clinical Emergency Hospital, 700111 Iasi, Romania.

出版信息

J Clin Med. 2024 Oct 12;13(20):6094. doi: 10.3390/jcm13206094.

DOI:10.3390/jcm13206094
PMID:39458044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11508869/
Abstract

Amiodarone, a bi-iodinated benzofuran derivative, is among the most commonly used antiarrhythmic drugs due to its high level of effectiveness. Though initially categorized as a class III agent, amiodarone exhibits antiarrhythmic properties across all four classes of antiarrhythmic drugs. Amiodarone is highly effective in maintaining sinus rhythm in patients with paroxysmal atrial fibrillation while also playing a crucial role in preventing a range of ventricular arrhythmias. Amiodarone has a complex pharmacokinetic profile, characterized by a large volume of distribution and a long half-life, which can range from several weeks to months, resulting in prolonged effects even after discontinuation. Side effects may include thyroid dysfunction, pulmonary fibrosis, and hepatic injury, necessitating regular follow-ups. Additionally, amiodarone interacts with several drugs, including anticoagulants, which must be managed to prevent adverse effects. Therefore, a deep understanding of both oral and intravenous formulations, as well as proper dosage adjustments, is essential. The aim of this paper is to provide a comprehensive and updated review on amiodarone's indications, contraindications, recommended dosages, drug interactions, side effects, and monitoring protocols.

摘要

胺碘酮是一种双碘代苯并呋喃衍生物,因其高效性而成为最常用的抗心律失常药物之一。尽管最初被归类为III类药物,但胺碘酮在所有四类抗心律失常药物中均表现出抗心律失常特性。胺碘酮在阵发性心房颤动患者中维持窦性心律非常有效,同时在预防一系列室性心律失常方面也起着关键作用。胺碘酮具有复杂的药代动力学特征,其特点是分布容积大、半衰期长,可从数周延长至数月,即使停药后仍有延长效应。副作用可能包括甲状腺功能障碍、肺纤维化和肝损伤,因此需要定期随访。此外,胺碘酮与多种药物相互作用,包括抗凝剂,必须加以管理以预防不良反应。因此,深入了解口服和静脉制剂以及正确调整剂量至关重要。本文旨在对胺碘酮的适应证、禁忌证、推荐剂量、药物相互作用、副作用和监测方案进行全面更新的综述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/11508869/1bc08c687f7b/jcm-13-06094-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/11508869/1622d6fd5139/jcm-13-06094-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/11508869/1bc08c687f7b/jcm-13-06094-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/11508869/1622d6fd5139/jcm-13-06094-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/11508869/1bc08c687f7b/jcm-13-06094-g001.jpg

相似文献

1
Amiodarone Therapy: Updated Practical Insights.胺碘酮治疗:最新实用见解
J Clin Med. 2024 Oct 12;13(20):6094. doi: 10.3390/jcm13206094.
2
Case Report: Amiodarone-induced multi-organ toxicity.病例报告:胺碘酮所致多器官毒性。
Front Cardiovasc Med. 2024 Jul 17;11:1401049. doi: 10.3389/fcvm.2024.1401049. eCollection 2024.
3
[Current role of amiodarone in antiarrhythmic therapy].[胺碘酮在抗心律失常治疗中的当前作用]
Herzschrittmacherther Elektrophysiol. 2010 Dec;21(4):239-43. doi: 10.1007/s00399-010-0091-0.
4
Amiodarone: a unique antiarrhythmic agent.胺碘酮:一种独特的抗心律失常药物。
Clin Pharm. 1983 Jul-Aug;2(4):330-40.
5
The role of amiodarone in contemporary management of complex cardiac arrhythmias.胺碘酮在复杂心脏心律失常当代治疗中的作用。
Pharmacol Res. 2020 Jan;151:104521. doi: 10.1016/j.phrs.2019.104521. Epub 2019 Nov 19.
6
Amiodarone-related thyroid dysfunction.胺碘酮相关的甲状腺功能障碍。
Intern Emerg Med. 2014 Dec;9(8):829-39. doi: 10.1007/s11739-014-1140-1. Epub 2014 Oct 28.
7
Comparative mechanisms of action of antiarrhythmic drugs.抗心律失常药物的作用机制比较
Am J Cardiol. 1993 Nov 26;72(16):13F-17F. doi: 10.1016/0002-9149(93)90959-g.
8
Arrhythmias in the intensive care patient.重症监护患者的心律失常
Curr Opin Crit Care. 2003 Oct;9(5):345-55. doi: 10.1097/00075198-200310000-00003.
9
Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.胺碘酮:电生理作用、药代动力学及临床效应
J Am Coll Cardiol. 1984 Apr;3(4):1059-71. doi: 10.1016/s0735-1097(84)80367-8.
10
nical rofile and ide ffects of chronic use of oral miodarone in cardiology outpatients department (CLIPSE-A Study)- A prospective observational study.心内科门诊慢性口服胺碘酮的临床特征及不良反应(CLIPSE-A研究)——一项前瞻性观察性研究。
Ann Med Surg (Lond). 2022 Jul 16;80:104167. doi: 10.1016/j.amsu.2022.104167. eCollection 2022 Aug.

引用本文的文献

1
The Role of Amiodarone in the Prevention of Postoperative Atrial Fibrillation After Surgical Myocardial Revascularization.胺碘酮在外科心肌血运重建术后预防术后房颤中的作用。
Med Arch. 2025;79(2):105-110. doi: 10.5455/medarh.2025.79.105-110.
2
Impact of Preventive Intravenous Amiodarone on Reperfusion Ventricular Fibrillation in Patients With Left Ventricular Hypertrophy Undergoing Open-Heart Surgery: Randomized Controlled Clinical Trial.预防性静脉注射胺碘酮对接受心脏直视手术的左心室肥厚患者再灌注室颤的影响:随机对照临床试验
JMIR Form Res. 2025 Jan 13;9:e64586. doi: 10.2196/64586.

本文引用的文献

1
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).2024年欧洲心脏病学会(ESC)心房颤动管理指南,与欧洲心胸外科学会(EACTS)联合制定。
Eur Heart J. 2024 Sep 29;45(36):3314-3414. doi: 10.1093/eurheartj/ehae176.
2
Effects of Glucagon-Like Peptide 1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-analysis.胰高血糖素样肽-1 受体激动剂对导管消融后心房颤动复发的影响:系统评价和荟萃分析。
Adv Ther. 2024 Oct;41(10):3749-3756. doi: 10.1007/s12325-024-02959-x. Epub 2024 Aug 14.
3
Adherence to monitoring of patients treated with amiodarone: a nationwide study.
胺碘酮治疗患者监测的依从性:一项全国性研究。
Front Med (Lausanne). 2024 Jul 5;11:1408799. doi: 10.3389/fmed.2024.1408799. eCollection 2024.
4
Amiodarone-Induced Epididymitis: A Case Report and Review of the Literature.胺碘酮所致附睾炎:一例病例报告及文献复习
Cureus. 2024 Jun 21;16(6):e62861. doi: 10.7759/cureus.62861. eCollection 2024 Jun.
5
GLP-1 receptor agonists and myocardial metabolism in atrial fibrillation.胰高血糖素样肽-1受体激动剂与心房颤动中的心肌代谢
J Pharm Anal. 2024 May;14(5):100917. doi: 10.1016/j.jpha.2023.12.007. Epub 2023 Dec 9.
6
Drug-Induced Myopathies: A Comprehensive Review and Update.药物性肌病:全面综述与更新
Biomedicines. 2024 Apr 30;12(5):987. doi: 10.3390/biomedicines12050987.
7
Drug-Induced Pseudoporphyria: A Case Report.药物性假性卟啉症:一例报告
Cureus. 2024 Apr 4;16(4):e57574. doi: 10.7759/cureus.57574. eCollection 2024 Apr.
8
The ion channel basis of pharmacological effects of amiodarone on myocardial electrophysiological properties, a comprehensive review.胺碘酮对心肌电生理特性的药理学作用的离子通道基础:全面综述。
Biomed Pharmacother. 2024 May;174:116513. doi: 10.1016/j.biopha.2024.116513. Epub 2024 Apr 1.
9
Epidemiology, prognosis, and challenges in the management of hyperthyroidism-related atrial fibrillation.甲状腺功能亢进相关心房颤动的流行病学、预后及管理挑战。
Eur Thyroid J. 2024 Apr 1;13(2). doi: 10.1530/ETJ-23-0254.
10
Monitoring thyroid function during amiodarone use.监测胺碘酮使用期间的甲状腺功能。
Br J Hosp Med (Lond). 2024 Jan 2;85(1):1-5. doi: 10.12968/hmed.2023.0214. Epub 2024 Jan 31.